Leadership Overview
ECRI has 6 executives leading key functions including medical safety, legal compliance, organizational strategy, general counsel, culture development, and historical leadership.
Committed to advancing healthcare quality through rigorous research, ECRI maintains a global reputation for independence and evidence-based decision support across all clinical settings.
Committed to advancing healthcare quality through rigorous research, ECRI maintains a global reputation for independence and evidence-based decision support across all clinical settings.
Leadership Roles at ECRI
Xiaojuan Wang - President
Xiaojuan Wang, the President at ECRI, architects the overarching strategic vision and operational growth of the organization. Overseeing the integration of research, technology, and patient safety services, the President drives the mission to improve healthcare quality globally. Xiaojuan Wang coordinates with the Board and executive leadership to expand the reach of evidence-based practices into new clinical markets. This leadership role involves managing the organizational transition following the affiliation with the Institute for Safe Medication Practices. By fostering a culture of innovation and rigorous inquiry, the President ensures that the organization remains the premier source for independent medical device evaluations. Wang directs the expansion of testing laboratories, strengthening the presence in both North America and the Asia Pacific region. Through decisive management of resources and talent, the President secures the financial and operational health of the nonprofit, ensuring that every initiative directly advances the safety and cost-effectiveness of healthcare.
David Marx - President, The Just Culture Company
David Marx, the President, The Just Culture Company at ECRI, leads the development and implementation of safety-focused organizational culture frameworks. Overseeing the methodology for improving accountability and transparency in healthcare, the President, The Just Culture Company ensures that clinical environments prioritize learning over blame. David Marx directs the training and consulting services that help hospitals adopt evidence-based safety practices. This leadership role involves working closely with healthcare leaders to transform institutional behaviors and reduce medical errors. By applying the principles of a just culture, the President, The Just Culture Company enhances the impact of the broader organization's research and technology support. Marx manages the expansion of these cultural initiatives across North American healthcare systems, driving systemic improvements in patient safety. Through the application of specialized safety models, Marx ensures that the organization remains at the forefront of healthcare quality, ultimately fostering environments where safety is the primary operational objective.
Joel Nobel - Founder and President Emeritus
Joel Nobel, the Founder and President Emeritus at ECRI, provides historical context and strategic guidance to the current leadership team. Overseeing the preservation of the organization's core values, the Founder and President Emeritus ensures that the commitment to independence remains central to all research activities. Joel Nobel directs the long-term vision for the organization, drawing upon decades of experience in medical technology evaluation. This leadership role involves mentoring executive staff and maintaining relationships with key stakeholders in the healthcare industry. By championing the importance of evidence-based practices, the Founder and President Emeritus reinforces the reputation for integrity that defines the organization. Nobel supports the ongoing mission to advance patient safety, ensuring that the foundational principles of rigorous testing and conflict-free research continue to guide all modern initiatives. Through this enduring influence, Nobel secures the legacy of the organization, ensuring that the commitment to healthcare quality remains steadfast across all global operations.
Dheerendra Kommala - Chief Medical Officer
Dheerendra Kommala, the Chief Medical Officer at ECRI, directs clinical strategy and patient safety initiatives across the global healthcare landscape. Overseeing evidence-based practice development, the Chief Medical Officer ensures that medical device evaluations meet the highest standards of clinical efficacy. Dheerendra Kommala collaborates with government agencies to refine safety protocols, driving improvements in patient outcomes through rigorous research. By integrating clinical data into technology decision support, the Chief Medical Officer optimizes resource allocation for hospitals. This leadership role involves managing complex medical research projects that span North America and the Asia Pacific region. Through constant monitoring of emerging health technologies, the Chief Medical Officer maintains the integrity of clinical evaluations. Ultimately, Kommala secures the organization's position as a trusted authority in healthcare safety, ensuring that every research output directly supports the mission of improving patient care quality and cost-effectiveness.
Randall White - Chief Legal Officer
Randall White, the Chief Legal Officer at ECRI, manages all corporate governance and regulatory compliance frameworks. Overseeing the legal department, the Chief Legal Officer protects the independence of the organization by enforcing strict conflict-of-interest policies. Randall White directs the legal strategy for international operations, ensuring alignment with diverse regulatory requirements across North America and the Asia Pacific region. This leadership role involves mitigating institutional risk while supporting the research-driven mission of the nonprofit. By providing counsel on intellectual property and contractual obligations, the Chief Legal Officer facilitates the secure dissemination of evidence-based healthcare data. White maintains rigorous standards for all organizational partnerships, ensuring that every collaboration upholds the reputation for integrity. Through proactive legal oversight, the Chief Legal Officer enables the organization to function as a federally certified Patient Safety Organization, ultimately safeguarding the long-term operational stability of the entire enterprise.
Ronni Solomon - Executive Vice President & General Counsel
Ronni Solomon, the Executive Vice President & General Counsel at ECRI, directs the legal affairs and strategic administrative functions of the organization. Overseeing the intersection of legal compliance and organizational policy, the Executive Vice President & General Counsel ensures that all research activities adhere to federal certification standards. Ronni Solomon manages the legal framework for the Patient Safety Organization designation, providing critical guidance on regulatory interactions with the U.S. Department of Health and Human Services. This leadership role involves navigating complex legal landscapes to protect the independence of the research laboratories. By advising on the integration of the Institute for Safe Medication Practices, the Executive Vice President & General Counsel supports the expansion of safety services. Solomon maintains the highest standards of ethical conduct, ensuring that the organization remains a trusted partner for government agencies. Through strategic legal planning, Solomon secures the operational continuity required to advance healthcare safety across all settings.
Explore Leadership Teams in Business Services
The US National Center for Atmospheric Research is a US federally funded research and development center managed by the nonprofit University Corporation for Atmospheric Research and funded by the National Science Foundation.
Company Leadership

GM
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership FB
GS

A global leader in applied safety science, UL Solutions transforms safety, security and sustainability challenges into opportunities for customers. We deliver testing, inspection and certification services, plus software and advisory offerings that support our customers product innovation and business growth.
Company Leadership

CZ
CS
The GLI Group of Companies form an inter-disciplinary approach to Compliance, Independent Verification & Validation (IV&V) and Quality Assurance (QA) testing solutions to our clients while meeting their cyber-security and other IT professional services needs. The GLI Group is made up of several entities as described below.
Company Leadership EH
TR
IT